These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 61330)

  • 21. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
    Chandrasekhar MR; Krishna BV; Patil AB
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibiotics. New aspects from the viewpoint of a microbiologist. Assumptions for significant use of antibiotics].
    Traub W
    Fortschr Med; 1974 Jun; 92(16):681-4. PubMed ID: 4599415
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of polymyxin E on Vibrio cholerae].
    Noworyta J
    Med Dosw Mikrobiol; 1978; 30(4):221-32. PubMed ID: 750785
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico.
    Parveen S; Farrah SR; Gonzalez-Bonilla C; Zamudio AV; Tamplin ML
    Can J Microbiol; 2003 Jan; 49(1):65-70. PubMed ID: 12674350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

  • 26. Vibrio cholerae non-O1 as a causal pathogen in cholera patients in Yangon, Myanmar.
    Oo KN; Than WM; Win T; Thida M; Aung KS
    J Diarrhoeal Dis Res; 1995 Sep; 13(3):176-9. PubMed ID: 8568194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibiotic susceptibility of Vibrio cholerae 01: evolution after prolonged curative and preventive use during the 2004 cholera epidemics in Douala (Cameroon)].
    Guévart E; Solle J; Mouangue A; Noeske J; Bita A; Fonkoua MC; Ndayo Wouafo M
    Med Mal Infect; 2006 Jun; 36(6):329-34. PubMed ID: 16757139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The status of antibiotic sensitivity of Vibrio cholerae 0:1 in Ecuador].
    Aldighieri S; Vela E; Pesantes C
    Med Trop (Mars); 1997; 57(1):98. PubMed ID: 9289622
    [No Abstract]   [Full Text] [Related]  

  • 29. [Activity of fourteen antibiotics on Vibrio cholerae el tor].
    Khemiri F; Hassine M
    Arch Inst Pasteur Tunis; 1980 Dec; 57(4):363-70. PubMed ID: 7271371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sensitivity to cotrimoxazole of bacteria isolated at the Central University Hospital of Fann, Dakar].
    Sow AI; Faye Niang MA; Dieng M; Toure K; Fall D; Soumare M; Seydi M; Ndour CT; Cisse MF; Samb A
    Dakar Med; 1999; 44(1):20-4. PubMed ID: 10797980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition of drug susceptibilities of Vibrio cholerae O1 in Lao People's Democratic Republic.
    Phantouamath B; Sithivong N; Sisavath L; Munnalath K; Khampheng C; Insisiengmay S; Higa N; Kakinohana S; Iwanaga M
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):95-9. PubMed ID: 11485103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characterization of a multiresistant strain of Vibrio cholerae O1, isolated from a case of cholera in Chile].
    Castillo L; Ulloa MT; Martínez MA; Silva W; Seoane M; Maldonado A; Castillo P
    Rev Med Chil; 1994 Sep; 122(9):986-92. PubMed ID: 7597345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
    Hung DT; Shakhnovich EA; Pierson E; Mekalanos JJ
    Science; 2005 Oct; 310(5748):670-4. PubMed ID: 16223984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro sensitivity of Vibrio cholerae serotype 0:139 to an intestinal antiseptic tiliquinol-tilbroquinol combination].
    Bougoudogo F; Fournier JM; Dodin A
    Bull Soc Pathol Exot; 1994; 87(1):38-40. PubMed ID: 8003903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vibrio cholerae strains resistant to vibriostatic factor 0/129 isolated from a patient with cholera in Poland].
    Stypułkowska-Misiurewicz H; Gardocka H; Sieczka Z
    Med Dosw Mikrobiol; 1994; 46(4):313-21. PubMed ID: 7603133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholera epidemic in and around Loni a rural area in western Maharashtra.
    Gujrathi UP; Sivarajan K; Kulkarni SG
    Indian J Pathol Microbiol; 2000 Jan; 43(1):101-2. PubMed ID: 12583433
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sensitivity of diarrhea organisms to nifuroxazide].
    Dodin A; Guillou M
    Bull Soc Pathol Exot Filiales; 1984; 77(3):295-7. PubMed ID: 6386203
    [No Abstract]   [Full Text] [Related]  

  • 38. The in vitro activity of Midecamycin against various Vibrio species.
    Bonang G; Surjawidjaja JE; Santoso US
    Jpn J Exp Med; 1975 Feb; 45(1):43-5. PubMed ID: 1228226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rapid method of determination of Pneumococcus sensitivity to antibiotics].
    Stuks IIu; Vintizenko ZIa
    Lab Delo; 1976; (4):252-3. PubMed ID: 66391
    [No Abstract]   [Full Text] [Related]  

  • 40. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
    Das S; Gupta S
    J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.